Clough Capital Partners LP Has Upped By $2.03 Million Its Tpg Specialty Lending (TSLX) Position; Loews Has Lowered Cvs Health (CVS) Stake

January 14, 2018 - By reb123z

Clough Capital Partners LP increased Tpg Specialty Lending Inc (TSLX) stake by 33.89% reported in 2017Q3 SEC filing. Clough Capital Partners LP acquired 101,400 shares as Tpg Specialty Lending Inc (TSLX)’s stock rose 6.27%. The Clough Capital Partners LP holds 400,563 shares with $8.40M value, up from 299,163 last quarter. Tpg Specialty Lending Inc now has $1.21B valuation. The stock increased 0.25% or $0.05 during the last trading session, reaching $20.06. About 128,182 shares traded. TPG Specialty Lending, Inc. (NYSE:TSLX) has risen 27.65% since January 14, 2017 and is uptrending. It has outperformed by 10.95% the S&P500.

Loews Corp decreased Cvs Health Corp (CVS) stake by 8% reported in 2017Q3 SEC filing. Loews Corp sold 20,000 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The Loews Corp holds 230,000 shares with $18.70 million value, down from 250,000 last quarter. Cvs Health Corp now has $79.81B valuation. The stock decreased 0.30% or $0.24 during the last trading session, reaching $78.78. About 7.10 million shares traded. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 14, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 65 analyst reports since July 22, 2015 according to SRatingsIntel. Deutsche Bank maintained it with “Hold” rating and $117 target in Wednesday, July 22 report. The stock of CVS Health Corporation (NYSE:CVS) has “Hold” rating given on Thursday, August 20 by Deutsche Bank. The stock of CVS Health Corporation (NYSE:CVS) earned “Buy” rating by Tigress Financial on Tuesday, December 26. As per Monday, December 4, the company rating was maintained by RBC Capital Markets. The stock has “Buy” rating by Leerink Swann on Monday, January 8. The rating was maintained by Citigroup on Thursday, August 17 with “Neutral”. The firm has “Outperform” rating given on Tuesday, November 7 by Leerink Swann. The rating was maintained by Citigroup with “Neutral” on Monday, May 9. Vetr upgraded the shares of CVS in report on Monday, August 24 to “Buy” rating. The company was initiated on Friday, April 28 by Tigress Financial.

Since August 16, 2017, it had 0 buys, and 7 sales for $58.32 million activity. Another trade for 241,150 shares valued at $20.03M was made by MERLO LARRY J on Wednesday, August 23. Roberts Jonathan C sold 85,743 shares worth $7.13 million. $7.19M worth of CVS Health Corporation (NYSE:CVS) was sold by Moriarty Thomas M. Foulkes Helena sold 39,340 shares worth $3.22 million. Denton David M had sold 237,078 shares worth $18.88M. SWIFT RICHARD J also sold $199,050 worth of CVS Health Corporation (NYSE:CVS) shares.

Investors sentiment decreased to 0.88 in Q3 2017. Its down 0.04, from 0.92 in 2017Q2. It fall, as 60 investors sold CVS shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Piedmont Advsrs Limited Liability Co has 284,891 shares for 0.49% of their portfolio. Hourglass Cap Lc stated it has 10,458 shares or 0.2% of all its holdings. Comm Natl Bank has invested 0.25% in CVS Health Corporation (NYSE:CVS). Ftb Advsr Inc invested 0.06% in CVS Health Corporation (NYSE:CVS). Linscomb & Williams invested 0.27% of its portfolio in CVS Health Corporation (NYSE:CVS). Pacad Inv Ltd stated it has 0.05% in CVS Health Corporation (NYSE:CVS). Rmb Capital Mngmt Lc holds 155,092 shares. The Iowa-based Cambridge Incorporated has invested 0.13% in CVS Health Corporation (NYSE:CVS). Oppenheimer Asset Mgmt Inc holds 0.05% or 25,367 shares in its portfolio. Hm Payson invested 0.11% of its portfolio in CVS Health Corporation (NYSE:CVS). First Midwest Bank & Trust Trust Division accumulated 0.17% or 16,903 shares. Mathes reported 4,684 shares stake. Rech Glob has invested 0.1% of its portfolio in CVS Health Corporation (NYSE:CVS). Carroll Fincl Assoc invested in 0.06% or 6,297 shares. Wellington Mngmt Grp Llp, a Massachusetts-based fund reported 16.97 million shares.

Analysts await CVS Health Corporation (NYSE:CVS) to report earnings on February, 8. They expect $1.90 EPS, up 11.11% or $0.19 from last year’s $1.71 per share. CVS’s profit will be $1.92 billion for 10.37 P/E if the $1.90 EPS becomes a reality. After $1.50 actual EPS reported by CVS Health Corporation for the previous quarter, Wall Street now forecasts 26.67% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts